Haemonetics (HAE) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $118.28 -2.48%
Revenue Growth %: +5.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
OMID, BCBP, BCML, More
Revenue Growth %: +5.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
OMID, BCBP, BCML, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $346 million versus the consensus estimate of $337.04 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Punjab National Bank (PNB:IN) PT Raised to INR130 at Kotak
- Punjab National Bank (PNB:IN) PT Raised to INR134 at JPMorgan
- Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
